drugset / Trial / NCT02255565
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine whether Quillivant XR is effective in the treatment of ADHD in children with Autism Spectrum Disorder (ASD).
Timeline
- Start
- 2014-09
- Primary completion
- 2016-09
- Completion
- 2016-10
Publications
- Background Gadow KD, DeVincent CJ, Pomeroy J. ADHD symptom subtypes in children with pervasive developmental disorder. J Autism Dev Disord. 2006 Feb;36(2):271-83. doi: 10.1007/s10803-005-0060-3.
- Background Lee DO, Ousley OY. Attention-deficit hyperactivity disorder symptoms in a clinic sample of children and adolescents with pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2006 Dec;16(6):737-46. doi: 10.1089/cap.2006.16.737.
- Background Rao, P. A. and R. J. Landa (2013).
- Background Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005 Nov;62(11):1266-74. doi: 10.1001/archpsyc.62.11.1266.
- Background Stein, M.A. et al.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 10 mg | Oral |
| Subject | Methylphenidate | Small molecule | 20 mg | Oral |
| Subject | Methylphenidate | Small molecule | 40 mg | Oral |